Literature DB >> 2880347

Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.

R B Dickson, A Kasid, K K Huff, S E Bates, C Knabbe, D Bronzert, E P Gelmann, M E Lippman.   

Abstract

The MCF-7 human breast cancer cell line responds to estrogen stimulation in vitro by increased secretion of growth factors and proliferation and in vivo by tumor formation in the nude mouse. To test a possible role of growth factor secretion in expression of the tumorigenic phenotype, we stably transfected MCF-7 cells with the v-Ha-ras oncogene to produce the MCF-7ras cell line. The MCF-7ras cell line was tumorigenic in the absence of estrogens and secreted 3- to 5-fold elevated levels of a high molecular weight form of a type alpha transforming growth factor-like growth factor, type beta transforming growth factor, and insulin-like growth factor I. MCF-7ras cells, in contrast to MCF-7, were less sensitive to further growth stimulation by estrogen, type alpha transforming growth factor, and insulin-like growth factor I and showed little change in receptor levels for these hormones. Conditioned medium from MCF-7ras cells as well as two of its component growth factors (insulin-like growth factor I and type alpha transforming growth factor) replaced estrogen in stimulating MCF-7 colony formation in vitro. A coordinate increase in growth factor secretion by human breast cancer may contribute to its escape from estrogen dependence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2880347      PMCID: PMC304311          DOI: 10.1073/pnas.84.3.837

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Increased secretion of type beta transforming growth factor accompanies viral transformation of cells.

Authors:  M A Anzano; A B Roberts; J E De Larco; L M Wakefield; R K Assoian; N S Roche; J M Smith; J E Lazarus; M B Sporn
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

2.  Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7).

Authors:  W B Butler; W L Kirkland; T L Jorgensen
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

Review 3.  Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?

Authors:  M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

4.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

Authors:  R W Furlanetto; J N DiCarlo
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

5.  Purification of human platelet-derived growth factor.

Authors:  H N Antoniades; C D Scher; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors.

Authors:  B Ozanne; R J Fulton; P L Kaplan
Journal:  J Cell Physiol       Date:  1980-10       Impact factor: 6.384

7.  Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis.

Authors:  H Kurachi; S Okamoto; T Oka
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Cellular transformation by coordinated action of three peptide growth factors from human platelets.

Authors:  R K Assoian; G R Grotendorst; D M Miller; M B Sporn
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

9.  Properties of a sarcoma-growth-factor-like peptide from cells transformed by a temperature-sensitive sarcoma virus.

Authors:  J E De Larco; Y A Preston; G J Todaro
Journal:  J Cell Physiol       Date:  1981-10       Impact factor: 6.384

10.  Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.

Authors:  A Kasid; M E Lippman; A G Papageorge; D R Lowy; E P Gelmann
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

View more
  43 in total

1.  Hydrolysis of transforming growth factor-alpha by cell-surface peptidases in vitro.

Authors:  Y Choudry; A J Kenny
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

2.  SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Authors:  Hiroyuki Ozawa; Ruchira S Ranaweera; Evgeny Izumchenko; Eugene Makarev; Alex Zhavoronkov; Elana J Fertig; Jason D Howard; Ana Markovic; Atul Bedi; Rajani Ravi; Jimena Perez; Quynh-Thu Le; Christina S Kong; Richard C Jordan; Hao Wang; Hyunseok Kang; Harry Quon; David Sidransky; Christine H Chung
Journal:  Clin Cancer Res       Date:  2017-05-18       Impact factor: 12.531

3.  Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.

Authors:  Huafeng Wei; Pu Liu; Elizabeth Swisher; Yuen Yee Yip; Jee Hang Tse; Kathy Agnew; Karl Erik Hellström; Ingegerd Hellström
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

4.  Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts.

Authors:  L J Joseph; L C Chang; D Stamenkovich; V P Sukhatme
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 5.  Kras and Tumor Immunity: Friend or Foe?

Authors:  Jane Cullis; Shipra Das; Dafna Bar-Sagi
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

6.  Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.

Authors:  Ewa Karna; Arkadiusz Surazynski; Kazimierz Orłowski; Joanna Łaszkiewicz; Zbigniew Puchalski; Piotr Nawrat; Jerzy Pałka
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

Review 7.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

8.  Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.

Authors:  Tiva T VanCleave; Jason H Moore; Marnita L Benford; Guy N Brock; Ted Kalbfleisch; Richard N Baumgartner; James W Lillard; Rick A Kittles; La Creis R Kidd
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

Review 9.  The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.

Authors:  C L Arteaga; T C Dugger; S D Hurd
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  17-beta-estradiol increases mitogenic activity of medium from cultured preadipocytes of massively obese persons.

Authors:  S C Cooper; D A Roncari
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.